T S Larson
Overview
Explore the profile of T S Larson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
854
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Amer H, Griffin M, Stegall M, Cosio F, Park W, Kremers W, et al.
Am J Transplant
. 2013 Apr;
13(6):1576-85.
PMID: 23601186
Postkidney transplant hyperparathyroidism is a significant problem. Vitamin D receptor agonists are known to suppress parathyroid hormone (PTH) secretion. We examined the effect of oral paricalcitol on posttransplant secondary hyperparathyroidism...
2.
Amer H, Lieske J, Rule A, Kremers W, Larson T, Franco Palacios C, et al.
Am J Transplant
. 2013 Feb;
13(3):676-84.
PMID: 23414180
Increased urinary protein excretion is common after renal transplantation and portends worse outcome. In this study we assessed the prognostic contribution of several urinary proteins. Urinary total protein, albumin, retinol...
3.
Raichlin E, Kushwaha S, Daly R, Kremers W, Frantz R, Clavell A, et al.
Transplant Proc
. 2011 Jun;
43(5):1871-6.
PMID: 21693292
Background: We analyzed the results of combined heart-kidney transplantation (CHKTx) over a 10-year period. Methods: Between September 1996 and May 2007 at Mayo Clinic, 12 patients (age 52 ± 12.2...
4.
Stegall M, Park W, Larson T, Gloor J, Cornell L, Sethi S, et al.
Am J Transplant
. 2010 Nov;
11(4):698-707.
PMID: 21062418
Previous studies suggest that the majority of renal allografts are affected by progressive, severe chronic histologic injury, yet studies using current protocols are lacking. The goal of this study was...
5.
Leung N, Shaikh A, Cosio F, Griffin M, Textor S, Gloor J, et al.
Am J Transplant
. 2010 Jan;
10(3):558-62.
PMID: 20055804
Nephrogenic systemic fibrosis (NSF) is a debilitating disease in patients with severely diminished kidney function. Currently, no standard treatment exists but improvement has been reported after restoration of kidney function....
6.
Issa N, Amer H, Dean P, Kremers W, Kudva Y, Rostambeigi N, et al.
Am J Transplant
. 2009 Jun;
9(8):1894-902.
PMID: 19519812
The incidence, risk factors and impact on patient and graft survival were evaluated for posttransplant lymphoproliferative disorder (PTLD) among 212 pancreas transplant recipients. Thirteen (6.1%) developed PTLD during 71 +/-...
7.
Babic N, Larson T, Grebe S, Turner S, Kumar R, Singh R
Clin Chem
. 2007 Dec;
52(11):2155-7.
PMID: 18050524
No abstract available.
8.
Dean P, Kudva Y, Larson T, Kremers W, Stegall M
Am J Transplant
. 2007 Nov;
8(1):175-82.
PMID: 17973965
Some patients do not achieve normoglycemia after an otherwise successful pancreas transplant. The aim of this study was to define the incidence and risk factors for the development of persistent...
9.
Amer H, Fidler M, Myslak M, Morales P, Kremers W, Larson T, et al.
Am J Transplant
. 2007 Oct;
7(12):2748-56.
PMID: 17941956
Proteinuria is associated with reduced kidney allograft survival. Herein we assessed the association between proteinuria, graft histology and survival. The cohort included 613 kidney allograft recipients who had proteinuria (measured)...
10.
Gloor J, Sethi S, Stegall M, Park W, Moore S, DeGoey S, et al.
Am J Transplant
. 2007 Jul;
7(9):2124-32.
PMID: 17608832
Transplant glomerulopathy (TG) usually has been described as part of a constellation of late chronic histologic abnormalities associated with proteinuria and declining function. The current study used both protocol and...